New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - idarubicin hydrochloride 10mg - powder for injection - 10 mg - active: idarubicin hydrochloride 10mg excipient: lactose monohydrate - latest regulatory activity

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - idarubicin hydrochloride 20mg - powder for injection - 20 mg - active: idarubicin hydrochloride 20mg excipient: lactose monohydrate

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - idarubicin hydrochloride 5mg - powder for injection - 5 mg - active: idarubicin hydrochloride 5mg excipient: lactose monohydrate

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - idarubicin hydrochloride - solution for injection - idarubicin hydrochloride 5 mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - doxorubicin hydrochloride (unii: 82f2g7bl4e) (doxorubicin - unii:80168379ag) - doxorubicin hydrochloride 2 mg in 1 ml - doxorubicin hydrochloride injection, usp has been used successfully to produce regression in disseminated neoplastic conditions such as acute lymphoblastic leukemia, acute myeloblastic leukemia, wilms'  tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, gastric carcinoma, hodgkin's disease, malignant lymphoma and bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types. doxorubicin is also indicated for use as a component of adjuvant therapy in women with evidence of axillary lymph node involvement following resection of primary breast cancer. patients should not be treated with doxorubicin if they have any of the following conditions: baseline neutrophil count <1,500 cells/mm 3 ; severe hepatic impairment; recent myocardial infarction; severe myocardial insufficiency; severe arrhythmias; previous treatment with complete cumulative doses of doxoru

Australia - English - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - mitozantrone hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - mitozantrone hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - mitozantrone hydrochloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - idarubicin hydrochloride - solution for injection - 1 milligram(s)/millilitre - anthracyclines and related substances; idarubicin

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - idarubicin hydrochloride - capsule, hard - 10 milligram(s) - anthracyclines and related substances; idarubicin